ShanXi C&Y Pharmaceutical Group Co.,LTD. (SHE:300254)

SHE:300254 Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 29, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Market Capitalization	2,710	2,173	2,327	1,636	1,981	1,571
Market Cap Growth	34.72%	-6.62%	42.24%	-17.43%	26.13%	-7.02%
Enterprise Value	3,361	2,352	2,579	1,773	2,248	1,769
Last Close Price	10.58	8.75	9.63	6.77	8.69	6.89
PE Ratio	280.36	51.50	92.35	-	-	-
Forward PE	-	47.48	47.48	47.48	47.48	47.48
PS Ratio	3.31	2.57	2.91	1.97	2.13	1.85
PB Ratio	5.16	3.63	2.99	2.24	2.66	1.80
P/TBV Ratio	-	-	25.93	32.48	68.49	21.65
P/FCF Ratio	218.39	111.77	596.91	34.01	33.02	-
P/OCF Ratio	82.25	30.63	61.53	21.85	20.44	-
EV/Sales Ratio	4.11	2.78	3.23	2.14	2.42	2.09
EV/EBITDA Ratio	29.36	20.66	33.20	51.17	63.24	-
EV/EBIT Ratio	60.86	37.35	102.75	-	-	-
EV/FCF Ratio	270.80	120.98	661.62	36.87	37.47	-
Debt / Equity Ratio	0.90	0.52	0.29	0.40	0.31	0.35
Debt / EBITDA Ratio	4.12	2.58	2.71	7.02	5.92	-
Debt / FCF Ratio	37.97	16.03	58.03	6.01	3.83	-
Asset Turnover	0.55	0.57	0.53	0.53	0.56	0.47
Inventory Turnover	1.84	2.23	2.32	2.37	2.51	2.09
Quick Ratio	0.57	0.60	0.63	0.63	0.63	0.87
Current Ratio	0.94	0.88	0.96	0.85	0.94	1.18
Return on Equity (ROE)	6.21%	10.86%	6.46%	-13.28%	-9.22%	-31.08%
Return on Assets (ROA)	2.30%	2.64%	1.04%	-0.95%	-1.06%	-6.88%
Return on Capital (ROIC)	3.26%	4.11%	1.55%	-1.48%	-1.64%	-10.05%
Return on Capital Employed (ROCE)	5.50%	6.40%	2.50%	-	-	-
Earnings Yield	0.33%	1.94%	1.08%	-7.25%	-4.62%	-16.70%
FCF Yield	0.46%	0.90%	0.17%	2.94%	3.03%	-3.33%
Payout Ratio	182.14%	29.20%	52.84%	-	-	-
Buyback Yield / Dilution	0.49%	-0.20%	-1.89%	-4.00%	-6.92%	-2.25%
Total Shareholder Return	-	-0.20%	-1.89%	-4.00%	-6.92%	-2.25%

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.